trifluoperazine has been researched along with Nerve Pain in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent evidence of neuropathic pain among adults with sickle cell disease (SCD) reveals a need for adjuvant analgesic treatments for these patients." | 2.79 | Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease. ( He, Y; Molokie, RE; Suarez, ML; Wang, ZJ; Wilkie, DJ; Wittert, H; Yao, Y; Zhao, Z, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molokie, RE | 1 |
| Wilkie, DJ | 1 |
| Wittert, H | 1 |
| Suarez, ML | 1 |
| Yao, Y | 1 |
| Zhao, Z | 1 |
| He, Y | 1 |
| Wang, ZJ | 1 |
1 trial available for trifluoperazine and Nerve Pain
| Article | Year |
|---|---|
Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.
Topics: Adult; Analgesics; Anemia, Sickle Cell; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Female; | 2014 |